Stock data
Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (XENE) reported net income of -US$345.91M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$373.07M | -US$345.91M | — |
| 2024 | — | — | -US$279.30M | -US$234.33M | — |
| 2023 | — | — | -US$214.05M | -US$182.39M | — |
| 2022 | — | — | -US$129.14M | -US$125.37M | — |
| 2021 | — | — | -US$78.99M | -US$78.88M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$110.74M | — |
| 2026-03-31 | — | -US$102.30M | — |
| 2025-12-31 | — | -US$105.26M | — |
| 2025-09-30 | — | -US$90.90M | — |
| 2025-06-30 | — | -US$84.71M | — |
| 2025-03-31 | — | -US$65.05M | — |
| 2024-12-31 | — | -US$65.69M | — |
| 2024-09-30 | — | -US$62.79M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.